Skip to content 
Search

Latest Stories

NHS steps up HPV vaccine rollout for young people aged 16–25

NHS aiming for 90% uptake among girls by 2040

HPV vaccine 16 to 25

Many of those targeted missed their vaccine during school years

iStock

Highlights

  • NHS encourages unvaccinated people aged 16–25 to get the HPV vaccine
  • Over 418,000 school leavers in past three years missed vaccination
  • HPV vaccine protects against cervical and other related cancers
  • NHS aiming for 90% uptake among girls by 2040
  • Letters, emails, texts and NHS App alerts being used for reminders

NHS campaign targets unvaccinated young adults

The NHS is urging hundreds of thousands of young people aged 16 to 25 to come forward for the HPV vaccine, which protects against cervical and other types of cancer.

Many of those targeted missed their vaccine during school years. According to NHS England, over 418,000 children left school without receiving the HPV jab in the past three years.


As part of a national campaign to increase uptake, GP practices are contacting eligible patients using letters, text messages, emails and the NHS App.

Addressing regional disparities and missed vaccinations

The vaccine is routinely offered to boys and girls aged 12 to 13. However, government data from June 2024 highlighted regional inequalities in vaccine uptake. The lowest rates were reported in London, across both male and female Year 10 pupils during the 2023–2024 school year.

The UK Health Security Agency (UKHSA) and NHS England are now focusing on improving awareness and access for young adults who missed vaccination earlier in life.

HPV vaccine effectiveness and long-term plans

The NHS aims to eliminate cervical cancer by 2040 under its 10-Year Health Plan, which includes boosting vaccine uptake to 90% among girls and increasing participation in cervical screening.

The vaccine also helps prevent cancers of the mouth, throat, anus, penis and vagina caused by the human papillomavirus (HPV).

Introduced in 2021, the latest version of the HPV vaccine is more effective than the previous type. Long-term projections suggest it could reduce cases of women's cancer by 16% and HPV-related deaths by 9%.

Research in England shows that the vaccine prevents 90% of cervical cancer cases.

Catch-up vaccinations available for adults

Catch-up doses are available to:

  • Anyone up to age 25 who missed their school vaccination
  • Adults up to age 45 with immune-compromised conditions
  • Men who have sex with men

Dr Amanda Doyle, National Director for Primary Care and Community Services at NHS England, said:
“Too many lives are lost to cervical cancer. The hard work of NHS staff in vaccinating and screening as many people as possible will help us meet our ambition of wiping out this disease.”

Dr Sharif Ismail, Director of Public Health Analysis at UKHSA, added:
“Uptake of the HPV vaccination has dropped significantly since the pandemic, leaving thousands at greater risk. We urge all parents to return consent forms promptly, and young adults should speak to their GP about catch-up options. It’s never too late to get protected.”

More For You

Samaritans branch closures

Samaritans currently has 22,000 listening volunteers

Alamy

Samaritans to shut 100+ branches in UK and Ireland under major restructure

Highlights

  • Samaritans plans to close at least half of its 200 branches over the next 7–10 years
  • Volunteers to be moved into larger regional hubs and remote call handling to be piloted
  • Charity says model is unsustainable; changes aim to increase volunteer flexibility and service capacity
  • Some volunteers express concern over the loss of smaller branch camaraderie and safe spaces
  • Final decision expected in September following consultation

Mental health charity plans shift to larger hubs and remote volunteering

Samaritans has announced plans to close at least 100 of its 201 branches across the UK and Ireland in the next seven to ten years, as part of a major restructuring strategy aimed at improving service delivery and reducing infrastructure costs.

The charity, which operates a 24/7 mental health helpline, says it intends to move volunteers into larger regional centres and trial a remote volunteering model. The shift is intended to provide greater flexibility, increase the number of volunteers on shift at any time, and reduce spending on building maintenance.

Keep ReadingShow less
Mounjaro side effects

Social media has recently drawn attention to the psychological challenges

iStock

The silent emotional side effect of Mounjaro jabs users are just beginning to talk about

Highlights

  • Mounjaro (tirzepatide) is a diabetes drug also prescribed for weight loss
  • Users report emotional side effects, including low motivation and feeling “stuck”
  • A TikTok post describing the “slow middle” of weight loss struck a chord with others
  • The injection can support weight loss of up to 20% over a year
  • Drug is now sold in UK supermarkets including Tesco and Morrisons


While Mounjaro has become increasingly popular for aiding weight loss, users have begun highlighting a less-discussed side effect — an emotional downturn midway through treatment.

The medication, also known by its generic name tirzepatide, is a weekly injection originally developed to manage type 2 diabetes. It has since gained traction for its weight loss benefits, with some patients shedding up to 20% of their body weight over the course of a year.

Keep ReadingShow less
Bryan Johnson

He now believes that commercial interests may be at odds with his philosophical mission

Getty Images

Bryan Johnson may shut down anti-ageing startup to focus on religion

Highlights

  • Bryan Johnson, 47, is contemplating shutting down or selling his anti-ageing startup, Blueprint.
  • The biotech entrepreneur recently launched a religion called "Don’t Die."
  • He says commercial activity is undermining his philosophical credibility.
  • Blueprint has faced financial pressures but Johnson denies any crisis.

Biotech entrepreneur and longevity enthusiast Bryan Johnson has revealed he is considering shutting down or selling his anti-ageing company, Blueprint. Speaking to Wired, the 47-year-old said his priorities have shifted towards developing his newly founded religion, "Don’t Die", which he believes better aligns with his philosophical ambitions.

“I am so close to either shutting it down or selling it,” Johnson said in the interview published Monday. “I don’t need the money, and it’s a pain-in-the-ass company.”

Keep ReadingShow less
Donald Trump health 2025

The diagnosis has prompted a wave of public attention

Getty Images

What is chronic venous insufficiency, the condition Donald Trump is diagnosed with?

Highlights

  • President Donald Trump has been diagnosed with chronic venous insufficiency (CVI), a vascular condition affecting blood flow in the legs
  • CVI occurs when leg veins struggle to return blood to the heart, often leading to swelling and discomfort
  • The condition was confirmed following visible leg swelling and bruising
  • Though not life-threatening, CVI can worsen without treatment
  • Trump’s case has sparked public interest in the risks and management of the condition

Trump diagnosed with common but chronic vein condition

President Donald Trump has been diagnosed with chronic venous insufficiency, a condition that affects the proper circulation of blood in the legs. The announcement followed public speculation after Trump was seen with visible swelling in his lower legs and bruising on his hand during recent public appearances.

According to a statement from White House medical staff, tests ruled out more serious cardiovascular conditions. Trump, 79, remains under regular observation, with the condition described as benign and manageable.

Keep ReadingShow less
Babies born free of mitochondrial disease

8 babies have been born in the UK using genetic material from 3 people

iStock

Babies born free of mitochondrial disease using DNA from 3 people

Highlights

  • Eight babies were born in the UK using DNA from three individuals to prevent mitochondrial disease
  • The technique combines egg and sperm from parents with mitochondria from a donor egg
  • Legal in the UK since 2015; results show children are meeting expected milestones
  • One in 5,000 babies are born with mitochondrial disease; no known cure exists
  • Newcastle scientists pioneered the technique, now used under NHS specialist service

UK births mark milestone in preventing inherited mitochondrial disease

Eight babies have been born in the UK using genetic material from three people in a pioneering effort to prevent incurable mitochondrial disease, doctors have confirmed. The technique, developed by researchers in Newcastle, represents a significant breakthrough in reproductive medicine and genetic science.

These births are the first proven cases in the UK of healthy children being born free of devastating mitochondrial disorders thanks to this technique, which has been legal in the country since 2015.

Keep ReadingShow less